D. Galdermans

Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu

Jacques De Grève, Erik Teugels, Caroline Geers et al. · Lung Cancer · 2012 · 277 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer

Abdelbari Baitar, Frank Van Fraeyenhove, A. Vandebroek et al. · Journal of Geriatric Oncology · 2012 · 136 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma

Jacques De Grève, Teresa Morán, Marie-Pascale Graas et al. · Lung Cancer · 2015 · 89 citations

Medicine, Oncology, Pharmacology +12

Are patients’ preferences for information and participation in medical decision-making being met? Interview study with lung cancer patients

Koen Pardon, Reginald Deschepper, Robert Vander Stichele et al. · Palliative Medicine · 2010 · 61 citations

Nursing, Oncology, End-of-life Care +16

Preferences of Patients with Advanced Lung Cancer Regarding the Involvement of Family and Others in Medical Decision-Making

Koen Pardon, Reginald Deschepper, Robert Vander Stichele et al. · Journal of Palliative Medicine · 2010 · 47 citations · Full text

Medicine, Oncology, Clinical Decision Support +16